Literature DB >> 10690328

Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure.

G Kojda1, D Harrison.   

Abstract

There is a growing body of evidence suggesting that numerous pathological conditions are associated with increased vascular production of reactive oxygen species. This form of vascular oxidant stress and particularly interactions between NO and oxygen-derived radicals represent a common pathological mechanism present in many so-called risk factors for atherosclerosis. Furthermore, reactive oxygen species seem to serve important cellular signalling mechanisms responsible for many of the features of vascular lesion formation. The mechanisms whereby vascular cells produce reactive oxygen species are only presently coming to light, and almost certainly will prove to be a focus for future therapies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10690328     DOI: 10.1016/s0008-6363(99)00169-8

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  155 in total

Review 1.  Vascular oxidant stress: molecular mechanisms and pathophysiological implications.

Authors:  G Zalba; J Beaumont; G San José; A Fortuño; M A Fortuño; J Díez
Journal:  J Physiol Biochem       Date:  2000-03       Impact factor: 4.158

2.  Rosuvastatin treatment protects against nitrate-induced oxidative stress in eNOS knockout mice: implication of the NAD(P)H oxidase pathway.

Authors:  Anne Otto; Jeanine Fontaine; Eric Tschirhart; David Fontaine; Guy Berkenboom
Journal:  Br J Pharmacol       Date:  2006-04-24       Impact factor: 8.739

Review 3.  Nitric oxide (NO) and obstructive sleep apnea (OSA).

Authors:  James S J Haight; Per Gisle Djupesland
Journal:  Sleep Breath       Date:  2003-06       Impact factor: 2.816

Review 4.  Exercise and the nitric oxide vasodilator system.

Authors:  Andrew Maiorana; Gerard O'Driscoll; Roger Taylor; Daniel Green
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

Review 5.  Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?

Authors:  Barry Halliwell; Matthew Whiteman
Journal:  Br J Pharmacol       Date:  2004-05       Impact factor: 8.739

6.  Effects of angiotensin receptor blockers on endothelial nitric oxide release: the role of eNOS variants.

Authors:  R Preston Mason; Robert F Jacob; Ruslan Kubant; Adam Jacoby; Febee Louka; J Jose Corbalan; Tadeusz Malinski
Journal:  Br J Clin Pharmacol       Date:  2012-07       Impact factor: 4.335

7.  Uric acid and insulin sensitivity and risk of incident hypertension.

Authors:  John P Forman; Hyon Choi; Gary C Curhan
Journal:  Arch Intern Med       Date:  2009-01-26

8.  Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice.

Authors:  Masanori Ozaki; Seinosuke Kawashima; Tomoya Yamashita; Tetsuaki Hirase; Masayuki Namiki; Nobutaka Inoue; Ken-ichi Hirata; Hiroyuki Yasui; Hiromu Sakurai; Yuichi Yoshida; Masahiro Masada; Mitsuhiro Yokoyama
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

9.  Heme-assisted S-nitrosation desensitizes ferric soluble guanylate cyclase to nitric oxide.

Authors:  Nathaniel B Fernhoff; Emily R Derbyshire; Eric S Underbakke; Michael A Marletta
Journal:  J Biol Chem       Date:  2012-10-23       Impact factor: 5.157

10.  Essential role of estrogen for improvements in vascular endothelial function with endurance exercise in postmenopausal women.

Authors:  Kerrie L Moreau; Brian L Stauffer; Wendy M Kohrt; Douglas R Seals
Journal:  J Clin Endocrinol Metab       Date:  2013-10-03       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.